Histogenics Lines up Big-Name Life Sci VCs for Mega A-Round

By Jonathan Marino — 3 years ago

Waltham, Mass.-based regenerative medicine developer Histogenics Corp. wrapped up a $49 million Series A round, the company revealed Tuesday. Sofinnova Ventures led the big round, and was joined by a litany of backers: Split Rock Partners, BioMed Ventures and FinTech GIMV Fund, L.P. invested for the first time, and were joined by ProChon Holdings BV, […]